Loading...
•
Dec 31, 2023
Exact Sciences Q4 2023 Earnings Report
Generated record revenue and positive free cash flow.
Key Takeaways
Exact Sciences Corp. reported a revenue of $647 million for the fourth quarter of 2023 and $2.50 billion for the full year of 2023. The company also generated positive free cash flow during the quarter.
Total fourth quarter revenue was $647 million, an increase of 17%, or 18% on a core revenue basis, with Screening revenue of $487 million and Precision Oncology revenue of $160 million
Total 2023 revenue was $2.50 billion, an increase of 20%, or 24% on a core revenue basis, with Screening revenue of $1.865 billion and Precision Oncology revenue of $629 million
Fourth quarter cash provided by operating activities was $70 million and free cash flow was $35 million
The company anticipates revenue of $2.810-$2.850 billion during 2024
Revenue by Segment
Forward Guidance
The company anticipates revenue of $2.810-$2.850 billion during 2024.
Positive Outlook
- Screening revenue of $2.155-$2.175 billion
- Precision Oncology revenue of $655-$675 million
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...